Amy C. Peterson - Oct 24, 2021 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
EVP, Chief Development Officer
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Amy C. Peterson
Stock symbol
CTMX
Transactions as of
Oct 24, 2021
Transactions value $
$0
Form type
4
Date filed
10/26/2021, 04:26 PM
Previous filing
Jun 8, 2021
Next filing
Feb 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTMX Stock Option (Right to Buy) Award $0 +50K $0.00 50K Oct 24, 2021 Common Stock 50K $5.34 Direct F1
transaction CTMX Performance Stock Units (PSUs) Award $0 +40K $0.00 40K Oct 24, 2021 Common Stock 40K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option vest on each monthly anniversary measured from October 24, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.
F2 Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date.